Nu Holdings Valuation
Is M1Z undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of M1Z when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: M1Z (€12.82) is trading above our estimate of fair value (€11.52)
Significantly Below Fair Value: M1Z is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for M1Z?
Key metric: As M1Z is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is M1Z's PE Ratio? | |
|---|---|
| PE Ratio | 36.5x |
| Earnings | US$1.78b |
| Market Cap | US$67.00b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | 1.3x |
Price to Earnings Ratio vs Peers
How does M1Z's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 12.7x | ||
CBK Commerzbank | 7.9x | 8.8% | €16.9b |
PCZ ProCredit Holding | 4.4x | 10.7% | €461.8m |
FCNC.A First Citizens BancShares | 12.8x | -8.2% | US$32.2b |
QNBTR QNB Bank | 25.6x | n/a | ₺914.6b |
M1Z Nu Holdings | 36.5x | 29.0% | €67.0b |
Price-To-Earnings vs Peers: M1Z is expensive based on its Price-To-Earnings Ratio (36.5x) compared to the peer average (12.7x).
Price to Earnings Ratio vs Industry
How does M1Z's PE Ratio compare vs other companies in the European Banks Industry?
| 2 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 2 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: M1Z is expensive based on its Price-To-Earnings Ratio (36.5x) compared to the European Banks industry average (7.3x).
Price to Earnings Ratio vs Fair Ratio
What is M1Z's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 36.5x |
| Fair PE Ratio | 17.7x |
Price-To-Earnings vs Fair Ratio: M1Z is expensive based on its Price-To-Earnings Ratio (36.5x) compared to the estimated Fair Price-To-Earnings Ratio (17.7x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €12.82 | €15.19 +18.5% | 16.2% | €18.14 | €7.64 | n/a | 20 |
| Nov ’25 | €13.36 | €13.90 +4.0% | 15.1% | €17.09 | €7.39 | n/a | 20 |
| Oct ’25 | €12.40 | €13.36 +7.7% | 15.5% | €16.55 | €7.16 | n/a | 20 |
| Sep ’25 | €12.91 | €12.96 +0.4% | 16.5% | €16.29 | €7.24 | n/a | 19 |
| Aug ’25 | €10.71 | €12.56 +17.3% | 14.9% | €15.62 | €7.35 | n/a | 19 |
| Jul ’25 | €11.65 | €12.19 +4.6% | 15.6% | €14.98 | €7.49 | n/a | 19 |
| Jun ’25 | n/a | €11.48 0% | 16.9% | €14.74 | €7.37 | n/a | 17 |
| May ’25 | €10.09 | €11.77 +16.6% | 13.9% | €15.02 | €7.98 | n/a | 17 |
| Apr ’25 | €11.11 | €11.07 -0.4% | 18.7% | €14.90 | €5.59 | n/a | 17 |
| Mar ’25 | €10.28 | €10.62 +3.4% | 19.3% | €14.76 | €5.54 | n/a | 17 |
| Feb ’25 | €8.24 | €9.66 +17.2% | 19.2% | €14.72 | €5.52 | n/a | 17 |
| Jan ’25 | €7.52 | €9.34 +24.3% | 20.2% | €14.86 | €5.57 | n/a | 17 |
| Dec ’24 | €7.39 | €9.11 +23.3% | 20.4% | €14.58 | €5.47 | n/a | 17 |
| Nov ’24 | €7.55 | €8.97 +18.8% | 25.0% | €15.07 | €3.77 | €13.36 | 17 |
| Oct ’24 | €6.98 | €8.06 +15.4% | 23.3% | €10.41 | €3.78 | €12.40 | 16 |
| Sep ’24 | €6.57 | €7.76 +18.1% | 23.9% | €10.14 | €3.69 | €12.91 | 16 |
| Aug ’24 | €7.14 | €7.44 +4.2% | 27.8% | €11.22 | €3.62 | €10.71 | 17 |
| Jul ’24 | €7.21 | €7.36 +2.1% | 27.7% | €11.37 | €3.67 | €11.65 | 17 |
| Jun ’24 | €6.46 | €7.04 +9.1% | 32.5% | €11.47 | €2.77 | n/a | 17 |
| May ’24 | €4.48 | €6.40 +42.8% | 35.2% | €11.39 | €2.73 | €10.09 | 18 |
| Apr ’24 | n/a | €6.60 0% | 34.1% | €11.76 | €2.82 | €11.11 | 18 |
| Mar ’24 | n/a | €6.62 0% | 34.7% | €11.72 | €2.81 | €10.28 | 18 |
| Feb ’24 | €4.22 | €6.21 +47.1% | 40.7% | €11.41 | €2.76 | €8.24 | 18 |
| Jan ’24 | €3.76 | €6.49 +72.5% | 38.5% | €11.61 | €2.81 | €7.52 | 18 |
| Dec ’23 | €4.12 | €6.73 +63.4% | 37.8% | €11.91 | €3.17 | €7.39 | 19 |
| Nov ’23 | €5.20 | €7.24 +39.2% | 41.3% | €12.70 | €3.35 | €7.55 | 17 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Crédit Agricole
€38.1b
Provides retail, corporate, insurance, and investment banking products and services in France and internationally.
XCA
€12.43
7D
-7.3%
1Y
6.2%
BNP Paribas
€62.8b
Provides various banking and financial products and services in Europe, the Middle East, Africa, the Americas, and the Asia Pacific.
BNP
€55.50
7D
-5.7%
1Y
-2.1%
Eurobank Ergasias Services and Holdings
€7.5b
Provides retail banking, corporate and private banking, asset management, treasury, capital market, and other services primarily in Greece, rest of Europe, and internationally.
EFGD
€2.03
7D
2.3%
1Y
23.4%